Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The molecular cartography of malignant and benign sebaceous tumours.

Nature communications·2025
Same author

S-100 protein expressing spindle cells in spindle cell lipoma: a diagnostic pitfall.

Virchows Archiv : an international journal of pathology·2016
Same author

[Histological spectrum of malignant melanoma].

Der Pathologe·2015
Same author

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.

British journal of cancer·2012
Same author

Postradiation vascular proliferations: an increasing problem.

Histopathology·2005
Same author

Multi-exon deletions of the FBN1 gene in Marfan syndrome.

BMC medical genetics·2001
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.9K

[Cutaneous angiosarcoma: new aspects].

T Brenn1

  • 1Abteilung für Pathologie, Western General Hospital und University of Edinburgh, Crewe Rd, EH4 2XU, Edinburgh, Schottland, t_brenn@yahoo.com.

Der Pathologe
|January 16, 2015
PubMed
Summary
This summary is machine-generated.

Cutaneous angiosarcoma, a rare cancer, is hard to diagnose due to varied appearances and limited markers. This review covers its spectrum, focusing on new immunohistochemistry and genetic findings for accurate diagnosis.

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.6K

Related Experiment Videos

Last Updated: Apr 18, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.9K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.6K

Area of Science:

  • Oncology
  • Dermatopathology
  • Molecular Pathology

Context:

  • Cutaneous angiosarcoma is an aggressive vascular neoplasm.
  • Diagnosis is challenging due to morphological variability and overlapping features with other tumors.
  • Conventional endothelial markers lack sensitivity and specificity.

Purpose:

  • To review the clinical and histological spectrum of cutaneous angiosarcoma.
  • To highlight novel immunohistochemical and molecular genetic findings.
  • To aid in differentiating cutaneous angiosarcoma from its mimics.

Summary:

  • Discusses the diverse clinical presentations and histological patterns of cutaneous angiosarcoma.
  • Emphasizes the limitations of current endothelial markers in diagnosis.
  • Presents updated information on immunohistochemistry and molecular genetics relevant to diagnosis.

Impact:

  • Aids pathologists in achieving more reliable and confident diagnoses of cutaneous angiosarcoma.
  • Improves diagnostic accuracy for this aggressive endothelial neoplasm.
  • Facilitates better patient management through earlier and more precise diagnosis.